Incidents Provoked Specifically by Certain Drugs Used in Anaesthesia

  • M. Klimek
  • T. H. Ottens
  • F. Grüne
Conference paper


One of the most frequent actions of an anaesthesiologist during the daily routine is the (intravenous) administration of drugs. This action alone offers many risks (e.g. wrong drug, wrong route, wrong dosage, wrong situation), but even when all these things are done right, there still remains the risk of incidents provoked by the drugs used. In this chapter, the term “incident” is used for any serious unwanted (and sometimes unexpected) effect of a drug, which is used with the best intentions for the patient’s health during anaesthesia and perioperative care. Of course, there is no drug without any theoretical side effect, so we will focus on relevant, preventable and/or treatable problems in the daily practice, where recent advances in evidence can be reported.


Lipid Emulsion Sevoflurane Anesthesia Hyperoxia Exposure Emergence Agitation Emergence Delirium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kleen M, Messmer K (1999) Toxicity of high PaO2. Minderva Anestesiol 65:393–396Google Scholar
  2. 2.
    Mathes DD (1995) Bleomycin and hyperoxia exposure in the operating room. Anaesth Analg 81:624–629CrossRefGoogle Scholar
  3. 3.
    Huettemann E, Sakka SG (2005) Anaesthesia and anti-cancer chemotherapeutic drugs. Curr opin Anaesthesiol 18:307–314PubMedCrossRefGoogle Scholar
  4. 4.
    Frerk CM, George N (2007) With bleomycin, that’s too much oxygen. Eur J Anaesthesiol 24:205PubMedCrossRefGoogle Scholar
  5. 5.
    Scheingraber S, Rehm M, Sehmisch C et al (1999) Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 90:1265–1270PubMedCrossRefGoogle Scholar
  6. 6.
    Constable PD (2003) Hyperchloremic acidosis: the classic example of strong ion acidosis. Anesth Analg. 96:919–922PubMedCrossRefGoogle Scholar
  7. 7.
    Stephens R, Mythen M (2003) Optimizing intraoperative fluid therapy. Curr Opin Anaesthesiol 16:385–392PubMedCrossRefGoogle Scholar
  8. 8.
    Liolios A, Guerit JM, Scholtes JL et al (2005) Propofol Infusion Syndrome with shortterm large-dose infusion during surgical anaesthesia in an adult. Anesth Analg 100:1804–1806PubMedCrossRefGoogle Scholar
  9. 9.
    Bray RJ (1998) Propofol infusion syndrome in children. Paediatric Anaesthesia 8:491–499PubMedCrossRefGoogle Scholar
  10. 10.
    Kam PCA, Cardone D (2007) Propofol infusion syndrome. Anaesthesia 62:690–701PubMedCrossRefGoogle Scholar
  11. 11.
    Mohammad Z, Afessa B, Finkielman JD (2006) The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care 10:R105PubMedCrossRefGoogle Scholar
  12. 12.
    Murray H, Marik PE (2005) Etomidate for endotracheal intubation in sepsis: acknowledging the good while accepting the bad. Chest 127:707–709PubMedCrossRefGoogle Scholar
  13. 13.
    Annane D (2005) ICU physicians should abandon the use of etomidate! Intensive Care Medicine 31:325–326PubMedCrossRefGoogle Scholar
  14. 14.
    Karila C, Brunet-Langot D, Labbez F et al (2005) Anaphylaxis during anesthesia: results of a 12-year survey at a French pediatric center. Allergy 60:828–834PubMedCrossRefGoogle Scholar
  15. 15.
    Laxenaire MC, Mertes PM (2001) Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 87:549–558PubMedCrossRefGoogle Scholar
  16. 16.
    Mertes PM, Laxenaire MC (2003) Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 99:521–523CrossRefGoogle Scholar
  17. 17.
    Harboe T, Guttormsen AB, Irgens A et al (2005) Anaphylaxis during Anesthesia in Norway. Anesthesiology 102:897–903PubMedCrossRefGoogle Scholar
  18. 18.
    Moos DD (2005) Sevoflurane and emergence behavioral changes in pediatrics. J PeriAnesth Nurs 20:13–18PubMedCrossRefGoogle Scholar
  19. 19.
    Uezono S, Goto T, Terui K et al (2000) Emergence agitation after sevoflurane versus propofol in pediatric patients. Anesth Analg 91:563–566PubMedCrossRefGoogle Scholar
  20. 20.
    Nakayama S, Furukawa H, Yanai H (2007) Propofol reduces the incidence of emergence agitation in preschool-aged children as well as in school-aged children: a comparison with sevoflurane. J Anesth 21:19–23PubMedCrossRefGoogle Scholar
  21. 21.
    Mayer J, Boldt J, Röhm KD et al (2006) Desflurane anesthesia after sevoflurane inhaled induction reduces severity of emergence agitation in children undergoing minor earnose-throat surgery compared with sevoflurane induction and maintenance. Anesth Analg 102:400–404PubMedCrossRefGoogle Scholar
  22. 22.
    Breschan C, Platzer M, Jost R et al (2007) Midazolam does not reduce emergence delirium after sevoflurane anesthesia in children. Pediatr Anesth 17:347–352CrossRefGoogle Scholar
  23. 23.
    Wells LT, Rasch DK (1999) Emergence “delirium” after sevoflurane anesthesia: a paranoid delusion? Anesth Analg 88:1308–1310PubMedCrossRefGoogle Scholar
  24. 24.
    Lee A, Cooper MG, Craig JC et al (2007) Effects ofnonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev 18:CD002765Google Scholar
  25. 25.
    Tang IY, Murray PT (2004) Prevention of perioperative acute renal failure: what works? Best Pract Res Clin Anaesthesiol 18:91–111PubMedCrossRefGoogle Scholar
  26. 26.
    Jarnberg PO (2004) Renal protection strategies in the perioperative period best Pract Res Clin Anaesthesiol 18:645–660CrossRefGoogle Scholar
  27. 27.
    Zink W, Seif C, Bohl JRE et al (2003) The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades. Anesth Analg 97:1173–1179PubMedCrossRefGoogle Scholar
  28. 28.
    Zink W, Bohl, JRE, Hacke N et al (2005) The long term myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blocks. Anesth Analg 101:545–554CrossRefGoogle Scholar
  29. 29.
    Zink W, Graf BM (2004) Local anesthetic myotoxicity. Reg Anesth Pain Med 29:333–340PubMedCrossRefGoogle Scholar
  30. 30.
    Shupak RC (2007) Lipid emulsion for bupivacaine toxicity: too soon to celebrate? Anesthesiology 106:634–635PubMedCrossRefGoogle Scholar
  31. 31.
    Foxall G, McCahon R, Lamb J et al (2007) Levobupivacaine-induced seizures and cardiovascular collapse treated with Intralipid ® Anaesthesia 62:516–518PubMedCrossRefGoogle Scholar
  32. 32.
    Heavner JE (2007) Local anesthetics. Curr Opin Anaesthesiol 20:336–342PubMedCrossRefGoogle Scholar
  33. 33.
    Cohen S, Hunter CW, Yanni B et al (2006) Central anticholinergic syndrome strikes again. J Clin Anesth 18:399–400PubMedCrossRefGoogle Scholar
  34. 34.
    Röhm KD, Riechmann J, Boldt J et al (2007) Do patients profit from physostigmine in recovery from desflurane anaesthesia? Acta Anaesthesiol Scand 51:278–283PubMedCrossRefGoogle Scholar
  35. 35.
    Brown DV, Heller F, Barkin R (2004) Anticholinergic syndrome after anesthesia: A case report and review. Am J Ther 11:144–153PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • M. Klimek
    • 1
  • T. H. Ottens
    • 1
  • F. Grüne
    • 1
  1. 1.Department of AnaesthesiologyErasmus University Medical CentreRotterdamThe Netherlands

Personalised recommendations